Clinical Trial Update: Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating whether adding radiation therapy to immunotherapy improves outcomes in Merkel cell carcinoma; results were posted in 2024 and the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Merkel Cell Carcinoma, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-02-08